Danaher has agreed to acquire Cepheid for approximately $4 billion including debt, the companies said today, adding the molecular diagnostics developer and its tests to a buyer that recently narrowed ...
Danaher announced Tuesday that it has entered an agreement to acquire molecular diagnostics player Cepheid for approximately $4 billion. Cepheid specializes in molecular diagnostics and markets tests ...
(Reuters) - Danaher Corp said on Tuesday it would buy medical diagnostics company Cepheid in a deal valued at $4 billion, including debt, that will strengthen its presence in molecular diagnostics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback